Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Zdradzinski is active.

Publication


Featured researches published by Michael Zdradzinski.


American Journal of Medical Quality | 2017

Impact of Frailty and Sociodemographic Factors on Hospital Admission From an Emergency Department Observation Unit

Michael Zdradzinski; Michael P. Phelan; Sharon E. Mace

Understanding factors associated with an increased risk of hospital admission from emergency department (ED) observation units (OUs) could be valuable in disposition decisions. To evaluate the impact of frailty and sociodemographic factors (SDFs) on admission risk, patients in an ED OU were surveyed. Survey measures included SDFs, social habits, and frailty measured by the Katz Index of Independence in Activities of Daily Living. Of 306 surveyed, 18% were admitted and 82% were discharged. Demographics were similar between groups. More admitted patients responded positively to the Katz Index (28% vs 13%, P = .007; odds ratio = 2.73; 95% CI = 1.35-5.51). College graduation and current employment favored the discharge group, while admitted patients were more likely to receive Social Security disability insurance. Frailty remained associated with admission on multivariable analysis. Frailty, disability insurance, and lower education are predictors of admission from an OU and could serve as screening criteria in disposition decisions.


American Heart Journal | 2016

Contributors to and impact of residual shunting after device closure of atrial septal defects.

Michael Zdradzinski; Rachel Elkin; Joanne M. Lee; Athar M. Qureshi; Wael ElMallah; Richard A. Krasuski

BACKGROUND The prevalence of residual shunt in patients after device closure of atrial septal defect and its impact on long-term outcome has not been previously defined. METHODS From a prospective, single-institution registry of 408 patients, we selected individuals with agitated saline studies performed 1 year after closure. Baseline echocardiographic, invasive hemodynamic, and comorbidity data were compared to identify contributors to residual shunt. Survival was determined by review of the medical records and the Social Security Death Index. Survival analysis according to shunt included construction of Kaplan-Meier curves and Cox proportional hazards modeling. RESULTS Among 213 analyzed patients, 27% were men and age at repair was 47 ± 17 years. Thirty patients (14%) had residual shunt at 1 year. Residual shunt was more common with Helex (22%) and CardioSEAL/STARFlex (40%) occluder devices than Amplatzer devices (9%; P = .005). Residual shunts were more common in whites (79% vs 46%, P = .004). At 7.3 ± 3.3 years of follow-up, 13 (6%) of patients had died, including 8 (5%) with Amplatzer, 5 (25%) with CardioSEAL/STARFlex, and 0 with Helex devices. Patients with residual shunting had a higher hazard of death (20% vs 4%, P = .001; hazard ratio 4.95 [1.59-14.90]). In an exploratory multivariable analysis, residual shunting, age, hypertension, coronary artery disease, and diastolic dysfunction were associated with death. CONCLUSIONS Residual shunt after atrial septal defect device closure is common and adversely impacts long-term survival.


Journal of the American College of Cardiology | 2016

IMPACT OF DEVICE TYPE ON RESIDUAL SHUNT FOLLOWING PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE

Richard A. Krasuski; Michael Zdradzinski; Joanne Lee; Rachel Elkin; Wael El Mallah

Persistence of interatrial shunt after device closure of secundum atrial septal defect (ASD) and its clinical impact is unknown. From a prospective, single institution database of 408 patients, 215 had adequate agitated saline studies to assess shunt at 1 year (158 Amplatzer, 37 Helex and 20 with


Journal of Heart Valve Disease | 2015

Incremenal Value of Cardiac Magnetic Resonance for Assessing Pulmonic Valve Regurgitation.

Michael Zdradzinski; Rachel Elkin; Scott D. Flamm; Richard A. Krasuski


Journal of the American College of Cardiology | 2016

ALTERATIONS IN PHOSPHODIESTERASE 5 EXPRESSION AND β-ADRENERGIC RESPONSE IN THE HUMAN VOLUME-OVERLOADED RIGHT VENTRICLE

Richard A. Krasuski; Michael Zdradzinski; Wendy E. Sweet; Cynthia Chang; Gosta Pettersson; Christine S. Moravec


Archive | 2018

Exercise in Congenital Heart Disease

Rachel Elkin; Michael Zdradzinski; Richard A. Krasuski


Journal of the American College of Cardiology | 2017

PULMONARY VASCULAR RESPONSE TO NITRIC OXIDE AND SUBSEQUENT RESPONSE TO ADVANCED MEDICAL THERAPY IN INCIDENT PATIENTS WITH PULMONARY HYPERTENSION

Richard A. Krasuski; Alexander J. Blood; Kishan S. Parikh; Rachel Elkin; Michael Zdradzinski; Thomas M. Bashore


Journal of the American College of Cardiology | 2015

IMPACT OF PERSISTENT RIGHT TO LEFT SHUNT IN DEVICE-OCCLUDED ATRIAL SEPTAL DEFECTS

Michael Zdradzinski; Abraham Abernethy; Kathryn Stackhouse; Rachel Elkin; Mohamed Halane; Wael ElMallah; Richard A. Krasuski


Journal of the American College of Cardiology | 2015

IMPACT OF PULMONARY HYPERTENSION ON RIGHT HEART REMODELING FOLLOWING DEVICE CLOSURE OF ATRIAL SEPTAL DEFECTS

Michael Zdradzinski; Abraham Abernethy; Rachel Elkin; Kathryn Stackhouse; Mohammed Halane; Wael ElMallah; Richard A. Krasuski


/data/revues/00029149/unassign/S0002914914010558/ | 2014

Comparison of Long-Term Postoperative Sequelae in Patients With Tetralogy of Fallot Versus Isolated Pulmonic Stenosis

Michael Zdradzinski; Athar M. Qureshi; Robert W. Stewart; Gosta Pettersson; Richard A. Krasuski

Collaboration


Dive into the Michael Zdradzinski's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Athar M. Qureshi

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge